Carbinolamines and related structures—Potential alkylating metabolites of clinically active anticancer drugs
- 1 June 1983
- journal article
- research article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 102 (3) , 361-373
- https://doi.org/10.1016/0022-5193(83)90374-0
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolitesBritish Journal of Cancer, 1980
- Phosphorus-31 NMR investigations of phosphoramide mustard: evaluation of pH control over the rate of intramolecular cyclization to an aziridinium ion and the hydrolysis of this reactive alkylatorJournal of Medicinal Chemistry, 1979
- Metabolism of hydrazines and hydrazides by the intestinal microfloraCellular and Molecular Life Sciences, 1978
- The problem of specificity and selectivity of alkylating cytostatics; studies on N-2-chloroethylamido-oxazaphosphorinesZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamideBiochemical Pharmacology, 1974
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973
- Ammonoacetals. I. A New Class of Potential Antineoplastic Compounds1Journal of Medicinal Chemistry, 1964
- Synthese und Abbau cytostatisch wirksamer cyclischer N‐Phosphamidester des Bis‐(β‐chloräthyl)‐aminsAngewandte Chemie, 1958
- Chemotherapeutic Action of a Cyclic Nitrogen Mustard Phosphamide Ester (B 518-ASTA) in Experimental Tumours of the RatNature, 1958
- Preparation of N-Phosphorylated Derivatives of Bis-β-chloroethylamine1aJournal of the American Chemical Society, 1954